Release Date: 10/07/19 09:09 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 332.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%